Ethyl 2- (4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161797-99-5 Febuxostat Agbedemeji Mimọ>99.0% Factory
Ipese Kemikali Ruifu Febuxostat Awọn agbedemeji ibatan:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2- (3-Cyano-4-Hydroxyphenyl) -4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2- (3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2- (3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Orukọ Kemikali | Ethyl 2- (4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate. |
Awọn itumọ ọrọ sisọ | Febuxostat Intermediate |
Nọmba CAS | 161797-99-5 |
NỌMBA CAT | RF-PI1122 |
Iṣura Ipo | Ni Iṣura, Agbara iṣelọpọ 100 Toonu / Ọdun |
Ilana molikula | C13H13NO3S |
Òṣuwọn Molikula | 263.31 |
Ojuami Iyo | 180 ℃ |
Brand | Ruifu Kemikali |
Nkan | Awọn pato |
Ifarahan | Ina Yellow to Pa-White Powder |
Idanimọ | Nipasẹ HPLC;Nipasẹ HNMR |
Pipadanu lori Gbigbe | <0.50% |
Aloku lori Ighition | <0.30% |
Nikan Aimọ | <0.50% |
Lapapọ Awọn Aimọ | <1.00% |
Mimọ / Analysis Ọna | > 99.0% (nipasẹ HPLC) |
Igbeyewo Standard | Standard Enterprise |
Lilo | Agbedemeji ti Febuxostat (CAS: 144060-53-7) |
Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin
Ethyl 2- (4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate (CAS: 161797-99-5) ni a lo ninu iṣelọpọ ti Febuxostat (CAS: 144060-53-7), xanthine oxidase / xanthine dehydrogenase inhibitor.Ti a lo fun itọju hyperuricemia ati gout onibaje.40-120 mg / ọjọ febuxostat ni a fihan pe o munadoko ni idinku awọn ipele urate omi ara nigba ti a nṣakoso lati ṣakoso hyperuricemia ni awọn alaisan ti o ni gout.Fabuxostat jẹ awari nipasẹ Teijin Pharmaceuticals ati iwe-aṣẹ si TAP Pharmaceuticals (eyiti o jẹ apakan lọwọlọwọ ti Takeda Pharmaceuticals) ati pe a fọwọsi ni AMẸRIKA fun itọju hyperuricemia ni awọn alaisan ti o ni gout.